These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 29261361

  • 21. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
    Amela C, Pachón I, de Ory F.
    Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626
    [Abstract] [Full Text] [Related]

  • 22. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [Abstract] [Full Text] [Related]

  • 23. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M, Broder KR, Temte JL, Snider DE, Seward JF, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2010 May 07; 59(RR-3):1-12. PubMed ID: 20448530
    [Abstract] [Full Text] [Related]

  • 24. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.
    Wellington K, Goa KL.
    Drugs; 2003 May 07; 63(19):2107-26. PubMed ID: 12962524
    [Abstract] [Full Text] [Related]

  • 25. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C, Gougeon ML, Tondeur L, Poirier B, Seffer V, Desprès P, Consigny PH, Vray M, study group.
    Vaccine; 2017 Oct 27; 35(45):6166-6171. PubMed ID: 28958813
    [Abstract] [Full Text] [Related]

  • 26. Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study.
    Bianchi FP, Stefanizzi P, De Nitto S, Larocca AMV, Germinario C, Tafuri S.
    J Infect Dis; 2020 Feb 18; 221(5):721-728. PubMed ID: 31580436
    [Abstract] [Full Text] [Related]

  • 27. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
    Saffar MJ, Fathpour GR, Parsaei MR, Ajami A, Khalilian AR, Shojaei J, Saffar H.
    J Trop Pediatr; 2011 Oct 18; 57(5):347-51. PubMed ID: 21078605
    [Abstract] [Full Text] [Related]

  • 28. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S.
    Bone Marrow Transplant; 2004 Jun 18; 33(12):1187-90. PubMed ID: 15077129
    [Abstract] [Full Text] [Related]

  • 29. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
    Singh HK, Chiu YL, Wilkin T.
    AIDS Patient Care STDS; 2015 Sep 18; 29(9):461-4. PubMed ID: 26153909
    [No Abstract] [Full Text] [Related]

  • 30. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ, Li Q, Yan R, Zhou Y, Tang XW, Deng X, Xie SY, Chen ZP.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr 06; 51(4):336-340. PubMed ID: 28395468
    [Abstract] [Full Text] [Related]

  • 31. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
    Hanaoka M, Hisano M, Watanabe N, Sugawara K, Kambe Y, Kanda E, Sago H, Kato T, Yamaguchi K.
    Vaccine; 2013 May 01; 31(19):2343-7. PubMed ID: 23523405
    [Abstract] [Full Text] [Related]

  • 32. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 May 01; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

  • 33. Successes and challenges for preventing measles, mumps and rubella by vaccination.
    Bankamp B, Hickman C, Icenogle JP, Rota PA.
    Curr Opin Virol; 2019 Feb 01; 34():110-116. PubMed ID: 30852425
    [Abstract] [Full Text] [Related]

  • 34. Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: comparisons with injected MMR.
    Diaz-Ortega JL, Bennett JV, Castaneda D, Vieyra JR, Valdespino-Gomez JL, de Castro JF.
    Vaccine; 2010 Jan 08; 28(3):692-8. PubMed ID: 19861187
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study.
    de Menezes Martins R, Curran B, Maia Mde L, Ribeiro Md, Camacho LA, da Silva Freire M, Yamamura AM, Siqueira MM, Lemos MC, de Albuquerque EM, von Doellinger Vdos R, Homma A, Saganic L, Jarrahian C, Royals M, Zehrung D.
    Contemp Clin Trials; 2015 Mar 08; 41():1-8. PubMed ID: 25476584
    [Abstract] [Full Text] [Related]

  • 36. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad.
    Pediatr Infect Dis J; 2006 Jul 08; 25(7):615-22. PubMed ID: 16804432
    [Abstract] [Full Text] [Related]

  • 37. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.
    Nascimento Silva JR, Camacho LA, Siqueira MM, Freire Mde S, Castro YP, Maia Mde L, Yamamura AM, Martins RM, Leal Mde L, Collaborative Group for the Study of Yellow Fever Vaccines.
    Vaccine; 2011 Aug 26; 29(37):6327-34. PubMed ID: 21640779
    [Abstract] [Full Text] [Related]

  • 38. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L.
    MMWR Recomm Rep; 1998 May 22; 47(RR-8):1-57. PubMed ID: 9639369
    [Abstract] [Full Text] [Related]

  • 39. Response to measles-mumps-rubella vaccine in children with autism spectrum disorders.
    Gentile I, Bravaccio C, Bonavolta R, Zappulo E, Scarica S, Riccio MP, Settimi A, Portella G, Pascotto A, Borgia G.
    In Vivo; 2013 May 22; 27(3):377-82. PubMed ID: 23606694
    [Abstract] [Full Text] [Related]

  • 40. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003 May 22; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.